In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)

Carlotta Ranieri(University of Bari Aldo Moro), Nicoletta Resta(University of Bari Aldo Moro)
Neurogenetics
March 16, 2018
10.1007/s10048-018-0540-1
Cited by 83

Related Papers

Molecular and Functional Characterization of Three Different Postzygotic Mutations in PIK3CA-Related Overgrowth Spectrum (PROS) Patients: Effects on PI3K/AKT/mTOR Signaling and Sensitivity to PIK3 Inhibitors
|PLoS ONE|2015|81